Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
Abstract Background Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking...
Saved in:
Main Authors: | Colene Bentley (Author), Stuart Peacock (Author), Julia Abelson (Author), Michael M. Burgess (Author), Olivier Demers-Payette (Author), Holly Longstaff (Author), Laura Tripp (Author), John N. Lavis (Author), Michael G. Wilson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada
by: Colene Bentley, et al.
Published: (2018) -
Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs
by: Sarah Costa, et al.
Published: (2019) -
Understanding Contextual Factors in Cost, Quality and Priority Setting Decisions in Health; Comment on "Contextual Factors Influencing Cost and Quality Decisions in Health and Care: A Structured Evidence Review and Narrative Synthesis"
by: Stuart Peacock, et al.
Published: (2018) -
Deliberative Public Engagement with Science An Empirical Investigation /
by: PytlikZillig, Lisa M., et al.
Published: (2018) -
Deliberative Public Engagement with Science: An Empirical Investigation
by: PytlikZillig, Lisa M.
Published: (2018)